EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Targeting RPE Senescence Via Suppressing IL-6/IL-6R Signaling for Treating Retinal Degenerative Diseases

Tian Zhou, Ziqi Yang, Biyan Ni, Hong Zhou, Yang Zhou, Huiyi Xu, Xiaojing Lin, Shiya Lin, Wei Yi, Chang He, Xialin Liu

Investigative Ophthalmology & Visual Science · 2025-09-19 · 66 (12) · 44

DOI: 10.1167/iovs.66.12.44 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2025-09-19. Written by Tian Zhou and 10 co-authors. Institution: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, People's Republic of China. Major MEDLINE topics: Retinal Pigment Epithelium, Interleukin-6, Cellular Senescence, Receptors, Interleukin-6. Cited 5 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Progressive dysfunction of retinal pigment epithelium (RPE) cells is a crucial factor for retinal degeneration, leading to irreversible blindness with limited therapeutic options. Cellular senescence of RPE cells and inflammation are important hallmarks for retinal degeneration, but the underlying molecular mechanisms and potential interventions remain largely unexplored. This study aims to explore whether the IL-6/ IL-6R axis establishes a senescence-inducing circuit in RPE cells, and to evaluate the therapeutic efficacy of its inhibition in rescuing senescent RPE cells and degenerative retina.

Methods

Sodium iodate (NaIO₃)-induced retinal degeneration mouse models were established and subjected to intravitreal injections of IL-6 neutralizing antibody, or an IL-6R inhibitor tocilizumab, respectively. Conditional deletion of Stat3 in RPE cells was achieved via subretinal delivery of AAV vectors. RPE cells were isolated for single-cell RNA sequencing (scRNA-seq), qPCR, Western blotting, and immunofluorescence staining. Retinal structure and function were assessed using optical coherence tomography (OCT), hematoxylin and eosin (H&E) staining, and electroretinography (ERG).

Results

RPE underwent cellular senescence in NaIO3-induced degeneration, which was dependent on activation of the IL-6/IL-6R axis. IL-6 promoted the senescence of RPE and exacerbated retinal degeneration. In contrast, inhibition of IL-6 suppressed RPE senescence and facilitated recovery of retinal structure and function. Mechanistically, STAT3 activation was essential for IL-6-mediated cellular senescence. Notably, tocilizumab effectively blocked the IL-6/IL-6R/STAT3 signaling cascade, attenuated RPE senescence, and protected against retinal degeneration, expanding the indications of tocilizumab.

Conclusions

IL-6 and IL-6R/STAT3 signaling played an essential role in RPE senescence, and tocilizumab presents a translational opportunity in treating retinal degenerative diseases.

Subjects

MeSH terms (MEDLINE)

Retinal Pigment EpitheliumInterleukin-6Cellular SenescenceReceptors, Interleukin-6Antibodies, Monoclonal, HumanizedRetinal DegenerationInterleukin-6 InhibitorsAnimalsMiceSignal TransductionDisease Models, AnimalElectroretinographyMice, Inbred C57BLTomography, Optical CoherenceSTAT3 Transcription FactorBlotting, WesternIntravitreal InjectionsIodates

Substances

Interleukin-6Receptors, Interleukin-6Antibodies, Monoclonal, HumanizedSTAT3 Transcription FactorIodatesInterleukin-6 Inhibitorstocilizumabsodium iodate

Authors and institutions

  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, People's Republic of China.

Cite

APA

Zhou, T., Yang, Z., Ni, B., Zhou, H., Zhou, Y., Xu, H., Lin, X., Lin, S., Yi, W., He, C., & Liu, X. (2025). Targeting RPE Senescence Via Suppressing IL-6/IL-6R Signaling for Treating Retinal Degenerative Diseases. Investigative Ophthalmology & Visual Science, 66(12), 44. https://doi.org/10.1167/iovs.66.12.44

Vancouver

Zhou T, Yang Z, Ni B, Zhou H, Zhou Y, Xu H, et al. Targeting RPE Senescence Via Suppressing IL-6/IL-6R Signaling for Treating Retinal Degenerative Diseases. Investigative Ophthalmology & Visual Science. 2025;66(12):44. doi:10.1167/iovs.66.12.44

BibTeX
@article{Zhou2025,
  author = {Zhou, Tian and Yang, Ziqi and Ni, Biyan and Zhou, Hong and Zhou, Yang and Xu, Huiyi and Lin, Xiaojing and Lin, Shiya and Yi, Wei and He, Chang and Liu, Xialin},
  title = {Targeting RPE Senescence Via Suppressing IL-6/IL-6R Signaling for Treating Retinal Degenerative Diseases},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  volume = {66},
  number = {12},
  pages = {44},
  doi = {10.1167/iovs.66.12.44}
}
Start for free →